1 / 10

Uriel Y. Moreno- Nieves PhD Student

DC infected by the ANRS MVA HIV vaccine candidate prime NK cells with anti-HIV specific activity through a mechanism involving NKG2D and NKp46 on NK cells and membrane-bound IL-15 on DC. Uriel Y. Moreno- Nieves PhD Student. Introduction. NK cells : Anti-viral activity.

mina
Download Presentation

Uriel Y. Moreno- Nieves PhD Student

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DC infected by the ANRS MVAHIV vaccine candidate prime NK cells with anti-HIV specific activity through a mechanism involving NKG2D and NKp46 on NK cells and membrane-bound IL-15 on DC Uriel Y. Moreno-Nieves PhDStudent

  2. Introduction • NK cells : • Anti-viral activity. • First line of defense against viral pathogens. • Increasing evidence of adaptive immune features. • Cross-talk NK/DC: • Activation of NK cells. • Important for the induction of adaptive immunity. • MVA : Modified Vaccinia virus Ankara • Attenuated, non-replicating poxvirus. • MVAHIV : expression of Gag, Pol, Nef peptides.

  3. Background and Objectives • NK cells stimulated by MVAHIV-infected DC are able to better control HIV infection in DC. Objectives: • To test control of HIV-1 infection in other cell types by MVAHIV-stimulated NK cells. • To investigate the mechanisms of anti-HIV specific priming of NK cells.

  4. Material and methods CD4+ T cells PBMC Magnetic separation Ficoll NK cells Blood from Healthy donors Differentiation 7 days Monocytes DC Addition of DC and NK cells after 18 hours Control of HIV infection DC CD4+ T cells Analysis of anti-HIV specificity Infection of DC by MVA Priming of NK cells 4 days

  5. Control of HIV infection by NK cells is increased after MVAHIV priming Control of HIV infection HIV-infected DC DC CD4+ T cell Analysis of anti-HIV specificity Priming of NK cells 4 days CMV-infected DC HIV-infected CD4+ T cells Day 6 p.i. n=10 Day 7 and Day 10 p.i. n=8 and n=10

  6. Priming of NK cells by MVAHIV is modulated by NKG2D HIV-infected CD4+ T cells HIV-infected DC Day 7 p.i. n=8 Day 9 p.i. n=10

  7. NKG2D blockade during MVA priming decreases mbIL-15 expression on DC Expression of mbIL-15 on DC during MVA priming Modulation of mbIL-15 on DC by NKG2D and NKp46 24, 48 and 72 hours of priming n=7 72 hours of priming n=5

  8. IL-15 is important for the MVAHIV priming Implication of NKG2D and mbIL-15 during MVA priming Day 9 p.i. n=8

  9. Conclusions • NK cells primed by MVAHIV have increased anti-HIV activity. • Better control of HIV infection in DC and CD4+ T cells. • MVAHIV priming seems to be anti-HIV-1 specific. • NKp46 blockade during MVAHIV priming enhances subsequent control of HIV infection in DC. • NKG2D engagement during MVAHIVpriming is important for subsequent control of HIV infection in DC and CD4+T cells. • NKG2D regulates mbIL-15 expression on DC. • IL-15 is important for MVAHIVpriming. • Decreased mbIL-15 expression after NKG2D blockade during MVAHIV priming might be responsible for the decreased control of HIV infection in CD4+ T cells. • Possible contribution of NK cells in vaccine efficacy.

  10. Acknowledgements Daniel Scott-Algara Françoise Barré-Sinoussi Yves Lévy Jean-Saville Cummings Vincent Arnold Adrien Gilbert Kevin Yarbrough Céline Didier Thank you!

More Related